'Menopause made me forget my name'
Kirsty Dixon's life changed overnight when she started experiencing intense brain fog at 49 years old.
Kirsty, from York, was staring at her screen at work one day, when suddenly she could not remember what she was doing.
"I just asked myself 'What is my name?', and I couldn't even remember my own name.
"I felt like I was going mad, I thought it was only me."
The problems continued when she tried to access support.
"I thought, why aren't people listening to me?
"I've got something really serious going on but I can't get anyone to listen."
Kirsty was told by a doctor that what she had experienced was part of the menopause.
It is estimated that one in three women in the UK is going through the menopause at any given time.
Kirsty, learning and development adviser at the University of York, is working to raise awareness of the lesser-known symptoms and the huge impact they can have on people's lives.
"Before menopause I've always been a very bubbly person, very social, bit mischievous," she said.
"Menopause came along and just put a big thunder cloud over my head.
"I lost myself. The number of times my husband said 'I want my Kirsty back' while he was cuddling me and I was in floods of tears."
Kirsty spent the next four years "fighting it" as she could not believe that those were menopause symptoms.
Then, during lockdown, Kirsty found herself researching menopause for her work.
She stumbled across an article by someone who had experienced the same symptoms as her.
"I got that lightbulb moment that what I was experiencing was perfectly normal, I needed to understand it and know what I could do to help myself," she said.
"I went from having this constant cloud and feeling useless, to actually owning my journey."
Now aged 58, Kirsty runs two support groups for women experiencing the menopause, including a nature walking group around York, and a pop-up cafe in Acomb.
They are non-profit and everyone is welcome, regardless of age or gender.
She hopes the groups will encourage more people to talk about the lesser-known symptoms.
"When you're going through it, it can feel so lonely," she said.
"You feel like it's only you, and you think you're going mad.
"One of the most important things I say to people is get your support network around you, and that's family, friends, and groups like this."
Sarah Mortimer, 54, has been coming to the group since it started in 2022.
She experienced an uncommon symptom of self-diagnosed burning mouth syndrome during her menopause, which involves developing blisters in the mouth with a burning feeling.
"It can be really isolating, so to find groups like this is amazing," she said.
"It makes a huge difference, knowing there's other people going through the same rubbish that you're going through.
"It's that strength in numbers thing, and there's strength in the power of talking about the menopause."
The group is based in York, but people travel from as far as Leeds, Sheffield and Beverley to attend.
Kirsty says that it highlights an ongoing issue around the need for more support for people going through the menopause.
"No one else was running a menopause cafe in York, so it was obviously something that was missing."
She is calling for more groups like this so that people do not have to travel so far to get the support they need.
"What I will say now, is as a post-menopausal woman, I am the most confident, the strongest, most creative person.
"If someone said to me you can have your life again, without your menopause experience, actually, I'd say no, because it's what's made me the person I am today.
"If I can get through that, I can get through anything."
Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North or tell us a story you think we should be covering here.
'Fire service is helping me through the menopause'
'I mistook cancer signs for the menopause'
What's the point of the menopause?
NHS menopause advice
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
an hour ago
- Associated Press
Plexāā Closes $4.5 Million Funding Extension to Drive U.S. Launch of BLOOM43 Platform for Breast Surgery
LONDON--(BUSINESS WIRE)--Jul 8, 2025-- Plexāā, a MedTech startup behind the award-winning BLOOM 43 medical device for breast surgery, has announced the close of a $4.5 million funding extension round. The strategic capital infusion will support the imminent U.S. launch of BLOOM 43, while also laying the groundwork for future innovations. The funding also strengthens the company's position ahead of their planned Series A fundraising round. Complication rates in breast surgeries, which can include infection, skin necrosis and the need for additional surgeries, have been recorded as high as 30 percent. 1 BLOOM 43 is the world's first fully wearable medical device designed to help patients prepare for breast cancer surgery and reconstruction by harnessing the power of Supraphysiological Preconditioning ™. The new technique safely and intermittently thermally preconditions the skin causing the release of heat-shock proteins that cause vasodilation and increased blood flow to the area. This process has been shown to reduce wound healing complications in proof-of-concept clinical trials. Along with its BLOOM 43 companion app, the device has demonstrated substantial improvements in the patient experience and surgical readiness, harnessing the power of holistic Prehabilitation ™ and preconditioning. The company has already secured multiple partners for its upcoming U.S. commercial launch. 'I want to thank our team for the tremendous progress it has made to make this financing possible,' said Dr. Saahil Mehta, founder and CEO of Plexāā. 'Securing this funding validates confidence in our flagship technology and the concept of Supraphysiological Preconditioning ™, and it energizes the team as we prepare to bring BLOOM 43 to a wider patient population in the U.S. and beyond. The funds will support this pivotal launch and market expansion, as well as the exciting development of our technology platform – including devices and apps targeting additional surgical specialties and creating a whole new category in surgery.' Plexāā Ltd has been backed by TCP Health Ventures (the dedicated healthcare investment arm of The Capital Partnership group of companies) who led the Seed Round. This extension round comprises existing and new investors including TCP. Further investment includes over $1.6 million in i4i grant funding from the National Institute for Health and Care Research (NIHR), and $1.3 million from Thena Capital, a London-based VC firm backed by the British Business Bank and focused on digital health and fast-tracked Medtech. Tatum Getty, founding General Partner at THENA Capital added, 'Since 2023, we've been closely tracking Plexāā's progress and the development of its first device, BLOOM 43. We couldn't be more excited for Plexāā to become our first portfolio company for THENA Capital's Fund I. The company is solving a critical and under-addressed challenge across the surgical pathway- reducing post-operative complications for patients which also addresses the impact to both providers and payers. 'Saahil and his team bring together clinical, engineering, and operational expertise from some of the UK's leading institutions. Their bold ambition to scale globally, beginning with an imminent commercial launch in the U.S., is exactly the kind of UK MedTech leadership team we look to champion. Our fund's commercialisation support model is well-suited to help Plexāā expand into women's health and adjacent categories where better outcomes and patient experiences are urgently needed.' Plexāā plans to collaborate with clinicians, patients, and partners worldwide to make prehabilitation and preconditioning the standard of care for surgery — and to deliver transformative solutions that address unmet needs in surgical care. About Plexāā Plexāā is a pioneering UK-based MedTech company focused on improving surgical outcomes through devices and digital products. Its flagship device, BLOOM 43, enables patients to supraphysiologically precondition their skin, potentially reducing the risk of wound healing complications such as infection and skin necrosis, which affect one in three women undergoing breast surgery. Plexāā is also exploring the application of this technology in other surgical fields, including obstetrics for C-sections, orthopaedics for joint operations, and general and vascular surgery, with a commitment to improving pre-operative preparation for surgery and patient outcomes. About TCP Health Ventures TCP Health Ventures is the dedicated healthcare investment arm of The Capital Partnership group of companies, a multi-asset investment company with assets under management of $7 billion. Headquartered out of London, TCP Health Ventures manages assets of $ 225 million across 15+ investments in the med-tech space and has a med-tech investing experience of 10 years. About the NIHR The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by: NIHR is funded by the Department of Health and Social Care. Its work in low- and middle- income countries is principally funded through UK international development funding from the UK government. About THENA Capital THENA Capital is a London-based venture capital firm backing the world's next category-defining medical technologies. We invest in breakthrough companies transforming care experiences through digital health, fast-tracked medical devices, and clinical-grade innovation. THENA's debut Fund 1, focuses on high-impact, UK-founded technologies addressing unmet needs across women's health, oncology, cardiovascular disease, chronic conditions, and care delivery. With deep clinical, regulatory and operational expertise, THENA Capital partners with founders to unlock international scale, navigate complex markets, and build enduring category leaders in global healthcare. References 1 Annals of Translational Medicine, Dec 2023, Management of complications following implant-based breast reconstruction: a narrative review, Dean H. Meshkin 1^, Joseph M. Firriolo 1, Nolan S. Karp 2, Ara A. Salibian 1 View source version on CONTACT: Media Contacts: Sam Choinski Pazanga Health Communications [email protected] (860) 301-5058 [email protected] KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA NEW YORK INDUSTRY KEYWORD: TECHNOLOGY BIOTECHNOLOGY HEALTH CONSUMER APPS/APPLICATIONS SURGERY PROFESSIONAL SERVICES ONCOLOGY MEDICAL DEVICES SOFTWARE DATA ANALYTICS HEALTH TECHNOLOGY WOMEN DATA MANAGEMENT SOURCE: Plexāā Copyright Business Wire 2025. PUB: 07/08/2025 03:46 PM/DISC: 07/08/2025 03:46 PM


Health Line
2 hours ago
- Health Line
Little Man Syndrome: What Is It and How Can It Be Harmful?
Little man syndrome refers to the idea that shorter men are more likely to display overly aggressive or dominant behavior in order to overcompensate for their height. This term is based on a social stereotype and is not a medical diagnosis. Little man syndrome, also known as the Napoleon Complex, is the idea that shorter men may feel inferior due to their height and use aggressive or dominant behavior to compensate. However, this is not a real syndrome or medical diagnosis. Instead, it is based on a problematic social stereotype that can lead to negative mental health effects such as social anxiety, depression, and low self-esteem. It's important to remember that human behavior extends far beyond our physical appearance and can be influenced by many factors such as our lived experiences, cultural norms, and social environment. What is little man syndrome? Little man syndrome is often attributed to the French dictator Napoleon Bonaparte, stemming from the myth that he used aggressive leadership to compensate for his short height. In popular culture, the stereotype is used to describe someone who has an ' inferiority complex ' due to their height, which manifests in behaviors that are controlling, overly dominant, or aggressive. In some instances, it is also used to refer to men of any height who prioritize the need to be right over accepting new ideas or opinions. In other words, someone who is small or narrow-minded. How can it affect men's mental health? Even without aggressive or dominant behavior, the stereotype of little man syndrome can be damaging and negatively affect mental health. This is because it reinforces the toxic idea that shorter men should feel inadequate and that masculinity is about dominance and is linked to height and intimidation. It can lead to negative body image, which can worsen existing mental health conditions or trigger new ones. In fact, a 2025 review found that body image concerns in men can often lead to the development of: low self-esteem depression anxiety Calling out harmful behavior Let's be clear: A stereotype cannot be used to dismiss or justify abuse. Controlling, toxic, or aggressive behavior is the real issue here, not a person's appearance. While someone may feel insecure in a relationship, it is not ok if they: are aggressive, verbally or physically display unhealthy jealousy isolate you from friends or family are overly possessive use guilt to manipulate you Remember, someone may feel insecure about their self-image, but that is never an excuse for harmful or abusive behavior. It is not your responsibility to carry the weight of their emotions. The following organizations offer tools and resources to support people experiencing abuse: National Domestic Violence Hotline: Call 800-799-7233 24 hours a day, 7 days a week for support. StrongHearts Native Helpline: Call 844-762-8483 or chat with an advocate on the website. National Deaf Domestic Violence Hotline: Call 855-812-1001 or text START to 88788. Immigrant Legal Resource Center: Support and advocacy search tool for non-U.S. citizens. Why we need to challenge toxic masculinity Toxic masculinity can often promote damaging ideas about what it is to 'be a man.' It can lead to behaviors that are harmful to the individual as well as others. This includes: suppressing emotions and instead feeling as though you have to 'toughen up' exerting dominance in all areas of your life, including work and romantic relationships being overly competitive refusing to do tasks that are traditionally deemed 'feminine,' such as household work using intimidation, aggression, or violence as a way to maintain control It can sometimes lead to men feeling pressured into displaying the above harmful behaviors in order to be perceived as masculine or 'man enough.' Challenging these stereotypes and behaviors when possible and safe to do so can help increase emotional awareness around toxic masculinity and break down harmful societal expectations. The bottom line Little man syndrome, also known as the Napoleon Complex, is the idea that shorter men may feel inferior due to their height and use aggressive or dominant behavior to compensate. Even without aggressive or dominant behavior, the stereotype of little man syndrome can be damaging and negatively affect mental health. It can lead to symptoms such as social anxiety, depression, and low self-esteem.


Associated Press
3 hours ago
- Associated Press
Transforming Healthcare Ltd Launches the Healthcare Convergence Framework: A Pioneering AI/Robotics Readiness Assessment Tool for Healthcare
London, UK , July 08, 2025 (GLOBE NEWSWIRE) -- Transforming Healthcare Ltd, a leader in healthcare consultancy and innovation, has announced the global launch of the Healthcare Convergence Framework® (HCF), the world's first AI/Robotics Readiness Assessment Tool specifically designed for healthcare organisations. Developed by the esteemed physician and thriving healthcare strategist Dr. Pietro Emanuele Garbelli, this groundbreaking framework is set to revolutionise the way hospitals, clinicians, and decision-makers evaluate their preparedness for integrating artificial intelligence and robotics into patient care, governance, and clinical operations. The Healthcare Convergence Framework® AI/Robotics Assessment tool arrives at a pivotal moment in the healthcare industry, where the acceleration of AI technologies demands strategic, clinician-led implementation. This tool empowers healthcare organisations to assess their readiness while safeguarding the ethics, trust, and human essence of medicine. By providing a comprehensive evaluation, the HCF ensures that healthcare providers can navigate the complexities of AI integration with confidence and foresight. 'The launch of the Healthcare Convergence Framework® marks a significant milestone in our mission to enhance care quality and reduce systemic inefficiencies,' said Dr. Pietro Emanuele Garbelli, CEO of Transforming Healthcare Ltd. 'This tool is not just about technology readiness; it's about ensuring that the integration of AI and robotics is done ethically and with a focus on maintaining the human touch in medicine.' The tool is now publicly accessible via providing healthcare leaders and decision makers with an invaluable resource to guide their strategic planning and operational readiness. As AI continues to transform the healthcare landscape, the HCF offers a structured approach to embracing these advancements responsibly and effectively. Transforming Healthcare Ltd, founded by Dr. Garbelli, is dedicated to shaping intelligent, ethical, and future-ready healthcare systems. Through strategic frameworks like the Healthcare Convergence Framework® and high-impact advisory, the company empowers healthcare organisations, clinicians, and healthcare leaders and decision-makers to lead with clinical excellence in the digital age. Dr Pietro Emanuele Garbelli About Transforming Healthcare Ltd Transforming Healthcare Ltd is a forward-thinking consultancy and innovation company dedicated to shaping intelligent, ethical, and future-ready healthcare systems. Founded by Dr. Pietro Emanuele Garbelli, the company empowers hospitals, clinicians, and healthcare leaders to navigate the evolving intersection of medicine, AI, and robotics. Through strategic frameworks, like the Healthcare Convergence Framework®, and high-impact advisory, Transforming Healthcare Ltd helps organisations enhance care quality, reduce systemic inefficiencies, and lead with clinical excellence in the digital age. Press inquiries Transforming Healthcare Ltd Pietro Emanuele Garbelli [email protected] 07517463999 20-22 Wenlock Road London N1 7GU United Kingdom